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A B S T R A C T
Background
Sleep positioning systems can be prescribed for children with cerebral palsy to help reduce or prevent hip migration, provide comfort
to ease pain and/or improve sleep. As sleep disturbance is common in children with developmental disabilities, with impact on their
carers’ sleep, and as sleep positioning systems can be expensive, guidance is needed to support decisions as to their use.
Objectives
To determine whether commercially-available sleep positioning systems, compared with usual care, reduce or prevent hip migration in
children with cerebral palsy. Any negative effect of sleep positioning systems on hip migration will be considered within this objective.
Secondary objectives were to determine the effect of sleep positioning systems on: (1) number or frequency of hip problems; (2) sleep
patterns and quality; (3) quality of life of the child and family; (4) pain; and (5) physical functioning. We also sought to identify any
adverse effects from using sleep positioning systems.
Search methods
In December 2014, we searched CENTRAL, Ovid MEDLINE, Embase, and 13 other databases. We also searched two trials registers.
We applied no restrictions on date of publication, language, publication status or study design. We checked references and contacted
manufacturers and authors for potentially relevant literature, and searched the internet using Google.
Selection criteria
We included all randomised controlled trials (RCTs) evaluating whole body sleep positioning systems for children and adolescents (up
to 18 years of age) with cerebral palsy.
Data collection and analysis
Two review authors independently screened reports retrieved from the search against pre-determined inclusion criteria and assessed the
quality of eligible studies.
Members of the public (parent carers of children with neurodisability) contributed to this review by suggesting the topic, refining the
research objectives, interpreting the findings, and reviewing the plain language summary.
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Main results
We did not identify any randomised controlled trials that evaluated the effectiveness of sleep positioning systems on hip migration.
We did find two randomised cross-over trials that met the inclusion criteria in respect of secondary objectives relating to sleep quality
and pain. Neither study reported any important difference between sleeping in sleep positioning systems and not for sleep patterns or
sleep quality (two studies, 21 children, very low quality evidence) and pain (one study, 11 children, very low quality evidence). These
were small studies with established users of sleep positioning systems and were judged to have high risk of bias.
We found no eligible trials that explored the other secondary objectives (number or frequency of hip problems, quality of life of the
child and family, physical functioning, and adverse effects).
Authors’ conclusions
We found no randomised trials that evaluated the effectiveness of sleep positioning systems to reduce or prevent hip migration in
children with cerebral palsy. Nor did we find any randomised trials that evaluated the effect of sleep positioning systems on the number
or frequency of hip problems, quality of life of the child and family or on physical functioning.
Limited data from two randomised trials, which evaluated the effectiveness of sleep positioning systems on sleep quality and pain for
children with cerebral palsy, showed no significant differences in these aspects of health when children were using and not using a sleep
positioning system.
In order to inform clinical decision-making and the prescription of sleep positioning systems, more rigorous research is needed to
determine effectiveness, cost-effectiveness, and the likelihood of adverse effects.
P L A I N L A N G U A G E S U M M A R Y
Sleep positioning systems for children with cerebral palsy
Background
Hip migration (where the top of the thigh bone gradually moves away from the pelvis) affects a substantial number of children with
cerebral palsy and is often associated with pain. For some children with cerebral palsy, particularly those who are unable to walk,
equipment is sometimes recommended to help children sleep in positions that reduce or prevent hip migration. This equipment is
known as ’sleep positioning systems’ and can be prescribed along with equipment designed to support posture while sitting or standing,
or both, during the day. Together, these are referred to as 24-hour postural management programmes.
Families and health professionals need information about whether sleep positioning systems work in this way, to help them make
decisions about their use.
Review question
The aim of this review was to look for robust evidence from randomised controlled trials evaluating the effectiveness of sleep positioning
systems for children with cerebral palsy. Randomised controlled trials involve two groups of people; one of the groups receives the
treatment (experimental group), while the other group does not (control group), and the results are compared. To ensure the groups
are similar, deciding which group a person joins is based on chance (random), so that any differences in the results between groups, is
due only to the treatment (INVOLVE Jargon Buster).
Study characteristics
We carried out a comprehensive search for studies. The evidence is current to December 2014.
Key results
No randomised controlled trials were found that evaluated the effectiveness of sleep positioning systems to reduce or prevent hip
migration.
Two small randomised controlled trials compared children’s quality of sleep when they were using and not using their sleep positioning
system. One of these studies also examined pain when sleeping in and out of a sleep positioning system. These were cross-over trials
(see Cochrane Glossary). The children in these studies spent a few nights using their sleep positioning system and then a few nights
not using it, or the other way round. The order in which they either used or did not use the equipment was randomised.
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Twenty-one children with cerebral palsy, aged between 5 and 16 years, who were used to sleeping in sleep positioning systems took
part in the studies. One of the studies took place in a sleep laboratory and the other study took place in the children’s homes. Neither
study reported any differences in quality of sleep or pain whether using or not using their sleep positioning system. These results need
to be interpreted cautiously due to the small numbers of children involved and the fact that the children who participated were already
accustomed users of the equipment. There were also various weaknesses in the way the research was designed and reported.
Quality of the evidence
The quality of the current evidence regarding the effectiveness of sleep positioning systems for children with cerebral palsy is very low
and more robust research is needed to help families and professionals make informed decisions about whether to use this intervention.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Sleeping in a sleep positioning system compared with not sleeping in a sleep positioning system for children with cerebral palsy
Population: Children with cerebral palsy
Settings: United Kingdom (at home or in paediatric research laboratory)
Intervention: Sleeping in sleep positioning system
Comparison: Not sleeping in sleep positioning system
Outcomes Impact Number of participants
(studies)
Quality of the evidence
(GRADE)
Reduce hip migration/hip prob-
lems
No RCTs measured effect of
sleep positioning systems on hip
migration/hip problems
- -
Effect on sleep patterns and
quality
Limited data. A small number of
established users of sleep posi-
tioning systems showed no sig-
nificant difference in sleep qual-
ity indicators
21
(2 studies)
⊕©©©
Very low
Effect on quality of life of child
and family
No RCTs measured effect of
sleep positioning systems on
child and family quality of life
- -
Effect on pain Limited data. A small number of
established users of sleep posi-
tioning systems showed no sig-
nificant difference in levels of
pain
10
(1 study)
⊕©©©
Very low
Effect on physical functioning No RCTs measured effect of
sleep positioning systems on
physical functioning
- -
Adverse effects No RCTs measured harms or
reported adverse events
- -
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change
the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to
change the estimate.
Very low quality: We are very uncertain about the estimate.
GRADE: Grades of Recommendation, Assessment, Development and Evaluation.
RCTs: Randomised controlled trials.
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B A C K G R O U N D
Description of the condition
Cerebral palsy affects between 2 and 2.5 per 1000 children and
is one of the most common causes of serious childhood physical
disability (Stanley 2000). The definition of cerebral palsy as re-
ported by Rosenbaum 2007 is: “Cerebral palsy describes a group
of permanent disorders of the development of movement and pos-
ture, causing activity limitation, that are attributed to non-pro-
gressive disturbances that occurred in the developing fetal or in-
fant brain. The motor disorders of cerebral palsy are often accom-
panied by disturbances of sensation, perception, cognition, com-
munication, and behaviour, by epilepsy, and by secondary mus-
culoskeletal problems.”
The Surveillance and Cerebral Palsy in Europe group provides a
system to classify the types of motor impairment as spastic, dyski-
netic (dystonia and choreoathetosis), or ataxic (Cans 2000). Spas-
tic types are further classified according to the distribution as either
unilateral or bilateral. However, the terms ’hemiplegia’ for unilat-
eral involvement, ’diplegia’ when lower limbs are more affected
than upper limbs, and ’quadriplegia’ for four-limb ’total body’ in-
volvement are also commonly used to describe the topography of
spastic cerebral palsy.
The severity of movement disability can be classified into one of
five levels using the Gross Motor Function Classification System
(GMFCS), which has demonstrated good reliability and validity
(Palisano 1997). Children in Level I perform in sitting, standing
and walking much as their age-matched peers, albeit with qualita-
tive differences, while children in Level V have difficulty achieving
head and trunk postures, and any voluntary control of movement
due to their motor impairment.
Hip displacement is common in children with cerebral palsy and
can cause pain and loss of function, and have an effect on personal
care (Cornell 1995). Hip displacement refers to the migration of
the femoral head laterally from under the acetabulum (Wynter
2008). The amount of displacement is expressed as a migration
percentage (hip migration). The risk of hip displacement, defined
as an X-ray measured migration index of greater than 30%, in-
creases linearly by GMFCS Level from negligible in Level I to al-
most universal in Level V; overall, hip displacement is estimated to
affect about a third of childrenwith cerebral palsy (Soo 2006). The
risk of scoliosis also appears to increase with greater movement dis-
ability (Saito 1998) and spinal deformity is often associated with
hip problems (dislocation, dysplasia) and pelvic obliquity.
Hip surveillance is a process usingX-rays and clinical assessment to
screen the hips of children to identify and monitor early indicators
of progressive hip displacement. It has long been recommended
for children with bilateral spastic cerebral palsy who are not walk-
ing by 30 months of age (Scrutton 1997). Published guidelines in
Australia advocate a more stringent screening programme for all
children with cerebral palsy regardless of gross motor functional
ability. The guidelines recommend repeated measures at specific
intervals and include recommendations to monitor the hip status
of a defined group of more severely-affected children with hemi-
plegia (Wynter 2008). Surgical management of the hip is consid-
ered when the migration index exceeds 30%, and screening com-
bined with early surgical intervention has been proposed to ame-
liorate hip dislocation (Hägglund 2005).
Non-surgical interventions that aim to prevent hip migration and
displacement include botulinum toxin A or phenol injections to
reduce the deforming forces caused by spastic muscles, and also
positioningusing orthoses and equipment tomanage hip and body
posture in sitting, standing and lying (NICE 2012).
A consensus statement in 2006 proposed that children in GMFCS
Levels IV to V should begin 24-hour postural management pro-
grammes in lying as soon as possible after birth, in sitting from 6
months, and in standing from 12 months (Gericke 2006). Opin-
ions vary though; Gough 2009 queries whether children who are
most likely to develop deformity are also those who are least able
to adhere to a continuous postural management programme.
Postural management equipment is used to enable and promote
symmetry and comfort in sitting, standing and lying. Sometimes,
where joint deformity has become established, some level of pos-
tural asymmetry can be accommodated (Pountney 2006). Provi-
sion of postural management equipment for sitting and standing
enables people to experience their environment from a different
perspective. In addition, achieving these posturesmay enable func-
tioning in other ways, for instance using assistive technology to
communicate. The use of cushions, pillows, and towels to assist
the sleep positioning of children has long been advocated (Bower
2008). However, the provision of commercial sleep positioning
systems to support lying postures at night is more controversial.
Reduction or prevention of deformity is a priority for children
with cerebral palsy. As hip dislocation cannot be considered an
isolated event, and cannot be treated easily, hip migration needs to
be considered separately from other deformities (Scrutton 2009).
When outcomes are reported to be better when hip surgery is
performed as soon as indicated (Morris 2009), delaying surgery to
use conservative interventions requires robust evidence. Clinicians
and families need to know if sleep positioning systems are effective
to reduce or prevent hip migration and which children are most
likely to benefit.
Description of the intervention
Sleep positioning systems are commercially-available, individu-
alised, lying support systems that may contain one or more com-
ponent parts, which are held in position by a base layer or sheet
(Polak 2009). These sleep positioning systems are available in dif-
ferent sizes and are made from a variety of materials, including
special foams that conform to body shape or a series of straps that
hold the body in a neutral and symmetrical position. The system
applies or resists forces to maintain the posture, hence the forces
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must be applied over maximal surface areas available to minimise
pressure, and materials should be such that temperature regula-
tion is not compromised. The idea is that children sleep, posi-
tioned in this equipment, with the goal of maintaining one posi-
tion overnight. While the primary focus of this review was the use
of sleep positioning systems to prevent or reduce hip migration,
they are also prescribed to improve sleep and provide comfort at
night.
Establishing use of sleep positioning systems can be time-consum-
ing and resource-intensive. Families and clinicians need to collab-
orate to identify the particular needs of child and family. Typi-
cally, an occupational therapist or physiotherapist will assess the
correct support for each individual child before use and regularly
during use. An optimum posture is proposed to be supine with
symmetrical 30 degrees hip abduction and 30 degrees hip flexion.
However, compromises will be necessary to accommodate asym-
metry where deformity has already become established or to suit
individual preferences. The time it can take to establish a night
positioning habit varies, and the length of time that a child can
adhere to lying in the equipment (dosage) may need to be in-
creased gradually. Families and carers require training and ongoing
support to implement therapeutic positioning at night, including
lifting the child in and out safely, correct positioning in the sys-
tem, and any scope for repositioning within the device. Ongoing
review is necessary to ensure the child remains comfortable and
to modify the equipment for changing musculoskeletal demands
and also for growth. The availability of training, as well as fund-
ing for this equipment has been noted to be inconsistent in the
National Health Service (NHS) in the United Kingdom (UK)
(Humphreys 2012; Pountney 2009). The average purchase price
of these commercially-available sleep positioning systems is £500,
but can be around £1500 depending on size and needs (UK prices,
Polak 2009). In addition, on-going costs then include parent carer
training, therapist time for monitoring progress and adjustments
or renewal to accommodate growth, plus maintenance checks, re-
pairs and cleaning (Polak 2009).
Of all the available postural management equipment prescribed,
sleep positioning systems are reported to be the least used after pro-
vision, aremore often abandoned by families, or both (Humphreys
2012; Pountney 2009). In a survey of UK paediatric chartered
physiotherapists, Polak 2007 found that some parent carers would
not use sleep positioning systems due to a reluctance to alter the
child’s sleep pattern, concerns about the child’s comfort, lack of
immediate tangible benefit, and worries about additional postural
control on top of daytime postural management. Families may
also be concerned about the appearance and size of the equipment,
how portable it is, how easy it is to operate and keep clean, and
whether they will receive adequate instructions (Innocente 2014;
Polak 2007).
Why it is important to do this review
It is unclear whether the provision of sleep positioning systems
helps to prevent hip migration. As sleep positioning systems can
create other problems for the child and family, and canbe expensive
to purchase and maintain, evidence of cost effectiveness is also
crucially important.
A study evaluating postural management programmes, including
sleep positioning systems, suggested that children using postural
management experienced fewer hip problems compared to histor-
ical controls (Pountney 2009). These authors identified that sleep
positioning systems were the least used item of postural manage-
ment equipment and suggested that this may have been due to
families’ reluctance to interfere with a child’s sleep routine and in-
crease night-time disturbance. A case series of children using sleep
positioning systems identified that while most children adapted to
using the equipment, some children were unable to sleep in the
equipment, and a third left the study (Hankinson 2002). Another
survey indicated that many families encountered problems using
the equipment and needed support and education, particularly
in the early stages (Goldsmith 2000). Sleep problems in children
with developmental disabilities are much more common and se-
vere than in children who do not have a developmental disability
(Keenan 2007), and anything that might interfere with sleep may
not be well received by parents.
The evidence for postural management programmes appears lim-
ited and it is thought that further research is needed (Pountney
2006). Despite this, and the question of acceptability of sleep po-
sitioning systems, the prescription of this equipment is becoming
increasingly widespread. It is therefore important to determine
whether the provision of sleep positioning systems reduce or pre-
vent hip migration, as well as examining the effects on associated
outcomes such as sleep patterns, quality of life, and pain.
O B J E C T I V E S
To determine whether commercially-available sleep positioning
systems, compared with usual care, reduce or prevent further hip
migration in children with cerebral palsy. Any negative effect of
sleep positioning systems on hip migration was considered within
this objective.
Secondary objectives were to determine the effect of sleep posi-
tioning systems on: (1) number or frequency of hip problems;
(2) sleep patterns and quality; (3) quality of life of the child and
family; (4) pain; and (5) physical functioning. We also sought to
identify any other adverse effects of sleep positioning systems for
children with cerebral palsy.
Public involvement
Parent carers of children with disabilities contributed to this re-
view by identifying the topic at a question-generation event using
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the structured Population-Intervention-Comparator-Outcome
(PICO) format; subsequently parent carers helped to refine the
research objectives, interpret the findings, and write the plain lan-
guage summary. Parent carers were part of the ’Family Faculty’, a
group of parent carers who contribute to the research activities of
the Peninsula Cerebra Research Unit (PenCRU) (pencru.org), a
childhood disability research unit based in Devon, England.
This review is based on a published protocol (Lloyd 2011), and has
been prepared following theCochrane Handbook (Higgins 2011c),
and Standards for the reporting of new Cochrane Intervention
Reviews (MECIR 2012).
M E T H O D S
Criteria for considering studies for this review
Types of studies
We searched for randomised controlled trials (RCTs). Randomised
controlled trials are an experimental design where participants are
randomly allocated into treatment or control groups. The follow-
ing trials were eligible for inclusion:
• RCTs of sleep positioning systems versus usual care (which
may include the use of support in seating and standing,
botulinum toxin A, and surgery);
• RCTs comparing one sleep positioning system with
another; and
• RCTs comparing sleep positioning with other postural
management systems (e.g. seating or standing support).
Cross-over trials were considered as RCTs according to the guide-
lines in the Cochrane Handbook for Systematic Reviews of Interven-
tions (Higgins 2011b).
Types of participants
Children and adolescentswere defined as 18 years of age or younger
(where at least 50% of the study population was 18 years of age
or under), with a clinical diagnosis of cerebral palsy. We included
children with all types (spastic, ataxic, dyskinetic/athetoid) and
severity (GMFCSLevels I toV) of cerebral palsy.We only included
trials that involved individuals with other diagnoses if the data for
individuals with cerebral palsy could be extracted separately.
Types of interventions
Overnight use of any commercially-manufactured whole body
sleep positioning system (such as Chailey Lying Support
T M , DreamaT M , Sleepform®, Moonlite/MoonlightT M , Sym-
metrisleep®, SnoooooozeT M ), applied in any setting (i.e. in the
family home or in residential care). We excluded the use of sleep
positioning systems in hospital (e.g. neonatal units). We also ex-
cluded studies evaluating seating and standing supports without
sleep positioning systems, and studies evaluating orthoses worn at
night if they were not designed for the whole body.
Types of outcome measures
Primary outcomes
• Hip migration percentage as determined by frontal
anteroposterior, plain film radiograph, which measures the
percentage of the femoral head that lies outside the acetabulum
(Thomason 2014). Standardised measurement over time enables
improvement, deterioration or no change to be determined.
Secondary outcomes
• Number or frequency of hip problems (e.g. dislocations,
dysplasia, surgical interventions).
• Sleep patterns or sleep quality (e.g. time taken to get to
sleep, hours asleep, and number of awakenings as measured by
polysomnography, Actigraph, parent-reported).
• Quality of life of child and family (as measured by
standardised child- or parent-reported outcome measures such as
Pediatric Quality of Life Inventory (PedsQL) cerebral palsy
module, or Child Health Questionnaire (CHQ)).
• Pain (as measured by, for example, Paediatric Pain Profile
(PPP)).
• Physical functioning (as measured objectively by a validated
scale, such as the Gross Motor Function Measure (GMFM), or
through interview-assessment such as Pediatric Evaluation of
Disability Inventory (PEDI)).
• Adverse events (i.e. intolerability of sleep positioning
systems (child- or parent-reported)).
The timing at which outcomes were measured was vital. We ex-
pected to see relevant outcomes reported at baseline and an ap-
propriate time at follow-up. Hip migration might be plotted as
trajectory based on annual or six-monthly X-rays, or follow-up
after at least one or more years. Pain and sleep outcomes could
be measured and compared over shorter periods such as weeks or
months.
Search methods for identification of studies
We searched the following databases on 13 June 2012, 13 May
2014 and most recently on 3 December 2014. The searches were
not limited by date, language, publication status or study design.
• Cochrane Central Register of Controlled Trials
(CENTRAL; The Cochrane Library), 2014 Issue 12, and which
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includes the Specialised Register of the Cochrane
Developmental, Psychosocial and Learning Problems Group.
• Ovid MEDLINE In-Process and Other Non-Indexed
Citations, 1948 to December Week 48 2014.
• EMBASE (Ovid), 1974 to December Week 48 2014.
• CINAHL (Cumulative Index to Nursing and Allied Health
Literature; EBSCOhost), 1981 to current.
• Cochrane Database of Systematic Reviews (CDSR; The
Cochrane Library), 2014 Issue 12.
• Database of Abstracts of Reviews of Effects (DARE;The
Cochrane Library), 2014 Issue 12.
• Health Technology Assessment Database (HTA; The
Cochrane Library, 2014 Issue 12.
• NHS Economic Evaluation Database (EED; The Cochrane
Library), 2014 Issue 2.
• BNI (British Nursing Index; ProQuest), 1994 to 3
December 2014.
• HMIC (Health Management Information Consortium;
Ovid), 1979 to 3 December 2014.
• Conference Proceedings Citation Index - Science (CPCI-S;
Web of Science), 1990 to 3 December 2014.
• Conference Proceedings Citation Index - Social Sciences &
Humanities (CPCI-SSH; Web of Science), 1990 to 3 December
2014.
• PEDro (Physiotherapy Evidence Database; pedro.org.au),
all available years.
• OTSeeker (Occupational Therapy Systematic Evaluation of
Evidence; otseeker.com), all available years.
• Cochrane Methodology Register (CMR; The Cochrane
Library), 2014 Issue 12.
• Clinicaltrials.gov (clinicaltrials.gov), all available years.
• World Health Organisation International Clinical Trials
Registry Platform (ICTRP; who.int/ictrp/en), all available years.
• WorldCat (worldcat.org), all available years.
The search strategy combined terms for cerebral palsy with generic
terms for sleep positioning systems or brand name products. The
search strategies for each database are reported in Appendix 1.
In addition, we searched the reference lists of all full-text papers
retrieved to identify studies missed by the electronic searches. We
contacted the manufacturers of sleep positioning systems and au-
thors of relevant papers to ask if they were aware of any published
and unpublished research. We also conducted a general Internet
search using the search engine ’Google’, using terms from the
search strategy to capture any relevant grey literature.
Data collection and analysis
Methods archived for future updates of this review can be found
in the Additional Methods Table in Appendix 2 and our protocol
for this review (Lloyd 2011).
Selection of studies
Two authors (MR, SB) independently screened titles and abstracts
of papers to identify records of potential eligibility. Where neces-
sary, the full-text article was examined to determine relevance; two
papers were translated for this purpose. Two independent review
authors (SB and CM or SB andMR) then assessed each record for
inclusion in the review using the inclusion criteria set out above.
Where a review author was an author of a paper being considered
for inclusion, two review authors not involved in that study as-
sessed its eligibility. Disagreements were resolved through discus-
sion and consultation with a third author (JTC or MR).
Data extraction and management
Two review authors (SB, CM) independently extracted the rele-
vant data onto a data extraction form based on examples of forms
used by National Institute for Health Research (NIHR) Collabo-
ration for Leadership in AppliedHealth Research and Care, South
West Peninsula (PenCLAHRC) and a Cochrane template. The
review authors were not blinded to the study authors or journal
when extracting the data.We planned to resolve any disagreements
by discussion or with reference to a third person (GH) but no
disagreements arose. Relevance of the outcomes assessed was dis-
cussed with two parent carers. The following data were extracted
from all eligible trials.
• Study characteristics: Number of participants, inclusion
and exclusion criteria, type of intervention and comparison,
intervention characteristics (duration, frequency, setting, any
training received by parents in the use of the sleep positioning
system), and number of withdrawals.
• Participant characteristics: Gender, age, disease severity, and
type of cerebral palsy (e.g. spastic, ataxic, dyskinetic/athetoid).
• Outcome measures assessed after finishing the intervention
and at follow-up.
Assessment of risk of bias in included studies
Review authors assessed the methodological quality of each trial
which met the inclusion criteria using the ’Risk of bias’ tool de-
scribed in the Cochrane Handbook for Systematic Reviews of Inter-
ventions (Higgins 2011a). Two review authors (SB, CM) assessed
each study independently and resolved disagreements by discus-
sion with each other. Judgements were based on answering a spe-
cific question for each domain (sequence generation, allocation
concealment, blinding, incomplete outcome data, selective out-
come reporting and other sources of bias), to which the answer
’yes’ indicated a low risk of bias, and the answer ’no’ indicated a
high risk of bias. If insufficient detail was reported in the paper,
the judgement was ’unclear’ risk of bias.
Samples of childrenwith cerebral palsy inRCTs are often small and
heterogeneous, so randomisation is unlikely to produce equal dis-
tributions of known or unknown determinants of outcome (Blair
2004). The review authors considered the possibility of clinically-
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significant differences in baseline characteristics as another source
of bias when assessing studies, by looking to see whether minimi-
sation for characteristics such as age and hip migration status was
applied at baseline to reduce group differences (Altman 2005).
In line with Cochrane guidance, if one or more domains was
judged to indicate a high risk of bias, the review authors assessed
a study as having an overall high risk of bias (Higgins 2011a).
We presented the findings of the ’Risk of bias’ assessment in the
’Risk of bias’ table (beneath the Characteristics of included studies
table) and provided a narrative description in the Risk of bias in
included studies subsection.
Measures of treatment effect
Continuous outcomes
Where the reported summary statistics varied (mean and standard
deviation; or median and interquartile range), SB requested the
raw data from the authors. JM then re-analysed the data, so that
the same summary data could be reported across the studies. For
primary outcomes, we reported the mean difference (MD) with
95% confidence intervals (CIs).
Where a study had a large number of variables, we identified a
limited set of key variables for each outcome in advance of statisti-
cal analysis (Altman 1991; Higgins 2011b). This aimed to control
the rate of false positive results and avoid use of adjustments for
multiple comparisons, which make statistical tests more conser-
vative. The chosen key variables included those measured by all
of the included studies, and those which did not require the per-
formance of laboratory investigations, and so have the potential
to be more easily measured in future research. Whether they are
the key variables that should be measured for the outcomes under
consideration, is not the focus of this review.
Cross-over trials
For cross-over trials, we presented the results from paired t-tests.
We considered a P value less than 0.05 to be statistically significant.
For more information on additional methods archived for future
updates of this review, please see Appendix 2 or Lloyd 2011.
Unit of analysis issues
No unit of analysis issues arose for this review. For more infor-
mation on methods to overcome unit of analysis issues archived
for future updates of this review, please see Appendix 2 or Lloyd
2011.
Dealing with missing data
Study authors provided the raw data from their studies to enable
reanalysis. We collected the numbers of participants for whom no
outcome data were obtained and reported this information in the
’Risk of bias’ assessment.
Assessment of heterogeneity
There were insufficient trials to undertake an assessment of hetero-
geneity. For more information on methods to assess heterogeneity
archived for future updates of this review, please see Appendix 2
or Lloyd 2011.
Assessment of reporting biases
Outcome reporting bias
Where a study met the inclusion criteria, we examined the report
of the study to assess for selective outcome reporting. We assessed
the study as adequate if it met the following criteria.
• The study protocol was available and all of the study’s pre-
specified (primary and secondary) outcomes that were of interest
to the review were reported in the pre-specified way.
• The study protocol was not available, but it is clear that the
published reports included all expected outcomes, including
those that were pre-specified.
Publication and other reporting bias
We requested the start and end date of studies from the authors
to consider time-lag bias. Where we received this information, we
considered it in the ’Risk of Bias’ assessment. There were too few
included studies to enable other meaningful analysis. Please see
Appendix 2 or Lloyd 2011 for additional methods for assessing
publication and other reporting biases archived for future updates
of this review.
Data synthesis
We planned to perform a meta-analysis or provide a descriptive
review depending on the number of studies and the quality and
type of data extracted. The decision of whether or not to carry
out a meta-analysis was reached through consensus of three of the
authors (SB, CM, JM). The criteria for our decision was by con-
sideration of the methodological or clinical differences between
the included studies (including: measurement tools, experimen-
tal location, choice of metric, age of participants, type of motor
disorder, position adopted in sleep positioning system, history of
seizures, GMFCS Level, and type of sleep positioning system).
We concluded that it would be inappropriate to carry out a fixed-
effect meta-analysis because the assumption of no between-study
variation is implausible given the heterogeneity, and we rejected a
random-effects meta-analysis because “[if ] there are few studies or
if the studies are small, a random-effects analysis will provide poor
estimates of the width of the distribution of intervention effects”
(Deeks 2011 Section 9.5.4).
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We present a narrative review of the results in the Effects of
interventions section. This was produced consistently to include
the same elements of information for each study, and presented
in the same order. We only discussed patterns in the results in
relation to the key variables for the outcomes of this review and
only if significant differences were found.
We presented the findings in Summary of findings for the
main comparison in accordance with the recommendations of
the Cochrane Handbook and the Grades of Recommendation,
Assessment, Development and Evaluation (GRADE) approach
for rating the quality of a body of evidence (Schünemann 2011).
Using the GRADE approach, and a form based on a worksheet
from the Cochrane Effective Practice and Organisation of Care
(EPOC) group (EPOC 2015), we assessed themethodological de-
sign, risk of bias, inconsistency, indirectness, and imprecision of
the evidence for the outcomes reported in this review.
Subgroup analysis and investigation of heterogeneity
Insufficient trials were available to enable us to consider statistical
heterogeneity. Please see Appendix 2 or Lloyd 2011 for methods
for conducting subgroup analyses archived for future updates of
this review.
Sensitivity analysis
There were too few studies to enable us to perform these analyses.
Please see Appendix 2 or Lloyd 2011 for methods for conducting
sensitivity analyses archived for future updates of this review.
R E S U L T S
Description of studies
See Characteristics of included studies, Characteristics of excluded
studies, and Characteristics of ongoing studies.
Results of the search
The search results are presented in a PRISMA flow chart in Figure
1. The initial search was carried out in June 2012 and followed
by updated searches in May 2014 and December 2014. Our
searches identified a total number of 1636 records, 1621 of which
were retrieved by the electronic searches. Of the 37 full-text re-
ports that were retrieved following title and abstract screening, 15
(41%) were found through contact with manufacturers and au-
thors rather than through the electronic search. Although agree-
ment on exclusion was 100%, several full-text reports could have
been excluded for more than one reason (i.e. were both an inel-
igible intervention and an ineligible study design) (see Excluded
studies). In sum, we excluded 34 reports, identified one ongoing
study from one report (UKCRN ID 10914), and included two
studies (from two reports).
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Figure 1. Study flow diagram
Included studies
We found no RCTs that evaluated the effectiveness of sleep posi-
tioning systems to reduce or prevent hip migration.
Two cross-over studies (involving 21 children in total) met our in-
clusion criteria in respect of two secondary objectives: sleep quality
and pain (Hill 2009; Underhill 2012). Both studies, conducted in
Southern England, used randomised order of treatment (sleeping
in sleep positioning systems or not sleeping in sleep positioning
systems). Participants in both trials were children (12 boys, 9 girls
in total) with cerebral palsy, graded as Levels III to V according
to the GMFCS; aged 5 to 16 years; and established users of sleep
positioning systems. The Hill 2009 study, which the authors de-
scribed as a pilot, was conducted in a laboratory (one night with
and one night without sleeping in sleep positioning systems, with
at least three nights at home in between). Underhill 2012 was con-
ducted in the child’s home (four consecutive nights each sleeping
with or without sleep positioning systems).
Neither study reported the effects on hip migration. Hill 2009
measured outcomes in relation to sleep quality using polysomnog-
raphy and video recording. Underhill 2012 assessed sleep quality
by Actigraph and pain by parent-report using the PPP. While nei-
ther study explicitly set out to measure harms or adverse effects,
the outcomes measured were capable of showing negative and pos-
itive effects. Further details about these studies are provided in the
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Characteristics of included studies tables.
Excluded studies
Of the 37 full-text articles retrieved, 11 were descriptive papers,
and 7 did not look at either sleep positioning systems, cerebral
palsy, or whole body sleep positioning systems (i.e. they focused
instead on upper limb splints worn at night). Fifteen studies (from
16 reports), which did assess the interventions of interest but were
not RCTs and therefore did not meet our inclusion criteria are
listed in the Characteristics of excluded studies. Two of these re-
ports refer to the same study (Polak 2007).
Ongoing studies
We found one ongoing exploratory study, which would meet the
criteria for inclusion into this review. No outcome data were avail-
able at the time of writing. For further information about this
study, please see Characteristics of ongoing studies.
Risk of bias in included studies
Both included studies were judged to have a high risk of bias
overall. See Figure 2 and Characteristics of included studies.
Figure 2. Risk of bias summary: Review authors’ judgements about each risk of bias item for each included
study.
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Random sequence generation
Neither included study reported how the researchers generated
the allocation sequence to each treatment condition (Hill 2009;
Underhill 2012).
Allocation
Hill 2009 used a sealed-envelope method and was considered at
low risk of bias, while Underhill 2012 did not report how random
allocation to the sequence of treatments was concealed.
Blinding
No information is provided as to who did the polysomnography
or Actigraph outcomes assessments, nor the training or expertise
of those who completed it, in either of the included studies. While
blinding of the delivery of this intervention was not possible in
the included studies, a lack of blinding may have impacted the
subjective outcomes that were not measured by technology (scores
on the PPP and the video recording) (Wood 2008). Neither Hill
2009 or Underhill 2012 clearly described how analysts conducting
the outcome assessment were blinded to group assignment.
Incomplete outcome data
Twenty-one children in total were randomised to take part in the
included trials, but results are only available for 19 children. Both
studies provided details of exclusions from analysis.
Hill 2009 excluded one child due to pyrexial illness on the second
study night and only one rapid eye movement (REM) cycle being
recorded.
In the Underhill 2012 study, sleep data were not available for one
child as the Actiwatch failed. Another child only slept without the
sleep positioning system for two of the four intended nights ’due
to a severe reaction’, but their results are included in the analysis,
without explanation as to how the data were managed. Also, no
reasons were provided for the lack of pain scores for one of the
children.
Selective reporting
Authors of both included studies planned to assess other outcomes
specified in their protocol, which were then not reported. Hill
2009 planned to assess day-time function using the Cambridge
Neuropsychological Testing Battery (CANTAB). Underhill 2012
planned to assess number of night awakenings that lasted longer
than five minutes and percentage of the sleep period which was
motionless. Results for these outcomes were not reported.
Authors of both the included studies provided their start and end
dates. The Hill 2009 study was conducted from January to April
2007 and the Underhill 2012 study ran from January 2009 to
January 2011.
Other potential sources of bias
Both trials were of very short duration and performed under ’ex-
perimental’ rather than pragmatic conditions. Hill 2009 had a
washout period of a minimum of three nights, but the length of
time between the two conditions (sleeping or not sleeping in sleep
positioning systems) was not clear in Underhill 2012. Thus, the
risk of effects from one condition affecting the other cannot be
ruled out.
As the children were all established users of sleep positioning sys-
tems, it is also important to consider any possible effect of the order
of conditions (whether the children slept in their sleep positioning
system first or second). While Hill 2009 tested for a first-night ef-
fect and concluded that randomisation had adequately controlled
for period effects, no test was made for these period effects in the
Underhill 2012 trial.
In order for the data to be collected from one location only in
the Underhill 2012 trial (children in residential settings often go
home at the weekends), data were only collected for four nights.
However, as the authors report, Actigraph data are recommended
to be collected from a minimum of five nights.
Neither trial recruited the number of children needed for statisti-
cal power as per their protocol. Both trials recruited existing users
of sleep positioning systems, which limited the generalisability of
the results to new users of sleep positioning systems, as the chil-
dren in these studies were likely to have adapted to their use. In
the Hill 2009 trial, only 10 of the 22 children initially thought
to be eligible actually participated. Children were excluded if they
experienced uncontrolled nocturnal seizures, or by their own clin-
icians on the basis of unsettled domestic situations or extreme be-
havioural problems. This may have reduced the applicability of
the results to those with more complex health conditions or social
circumstances, or both.
Effects of interventions
See: Summary of findings for the main comparison
Primary outcomes
Hip migration percentage
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No included studies evaluated whether sleep positioning systems
reduce or prevent hip migration in children with cerebral palsy.
Secondary outcomes
Number or frequency of hip problems
No included studies evaluated whether sleep positioning systems
reduce or prevent hip problems in children with cerebral palsy.
Sleep patterns or sleep quality
Both included studies measured sleep quality. Hill 2009 presented
multiple variables (n = 18) for measuring sleep quality and carried
out Bonferroni adjustments of the significance level to correct for
multiple comparisons. We defined the key variables we thought
most closely fit the objectives of this review and would also be
comparable to variables measured by Underhill 2012. These were
sleep latency and sleep efficiency. We have reported the results of
paired t-tests for treatment effect for these key variables in Table
1. As we included very few key variables, we did not make any
adjustments to the significance level.
Sleep latency
Both included studies measured the time it took for the child to
fall asleep once put to bed (latency). In both studies, one child
fell asleep before the intervention commenced (bedtime). In the
study reported by Underhill 2012, this child’s data were excluded
from the analysis; in Hill 2009, the nil score (asleep at the point
recording began) was included in the analysis on the basis of in-
tention-to-treat (ITT). In order to enable comparison, the results
for Hill 2009, both including the nil score and without it, are set
out in Table 1.
Neither study found a statistically significant difference in the time
it takes for a child to fall asleep whether sleeping in the sleep
positioning system or not.
Sleep efficiency
Both included studies also measured the percentage of time the
childwas actually asleep in bed (efficiency).Neither study reported
a statistically significant difference whether sleeping in the sleep
positioning system or not.
Both included studies reported substantial individual variability.
As the Underhill 2012 data provided to us contained a sequence
of treatments, we carried out additional t-tests for a period effect
(Altman 1991). We found no significant difference for sleep effi-
ciency (t value = 0.67, P value = 0.52) or sleep latency (t value =
2.01, P value = 0.08). Hill 2009 tested for first-night effects and
also reported no significant differences between the nights studied.
No statistical difference was reported between sleeping in the
sleep positioning system or not in respect of any of the other 16
sleep quality variables measured by the included studies. Summary
statistics, which we calculated from raw data provided by study
authors, are presented in Table 2.
Quality of life of child and family
No studies meeting the inclusion criteria examined the impact of
sleep positioning systems on the quality of life of the child and
family.
Pain
One included study - Underhill 2012 - measured the impact of
sleep positioning systems on pain using the PPP. Parent-reported
pain scores for the children were recorded following four nights in
a sleep positioning system and compared to parent-reported pain
scores recorded following four nights out of the sleep positioning
system. The difference in pain scores of children sleeping in sleep
positioning systems compared to those sleeping without was not
statistically significant (see Table 1).
Physical functioning
No studies meeting the inclusion criteria explored the impact of
sleep positioning systems on physical functioning.
Adverse effects
Neither included study reported on any adverse effects.
D I S C U S S I O N
Summary of main results
We found no RCTs that examined the effectiveness of sleep po-
sitioning systems to reduce or prevent hip migration for chil-
dren with cerebral palsy (see Summary of findings for the main
comparison).
Very low quality evidence (two small randomised cross-over stud-
ies) found no differences in sleep quality or pain between using
a sleep positioning system or not, for existing users of sleep posi-
tioning systems. These findings need to be interpreted cautiously
and are difficult to generalise due to the high risk of bias and low
statistical power of these studies.
We found no studies meeting our inclusion criteria that assessed
possible adverse effects of sleep positioning systems, or the impact
of sleep positioning systems on physical functioning, the number
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or frequency of hip problems, or the quality of life of the child
and family.
Overall completeness and applicability of
evidence
We found insufficient high quality evidence to address the objec-
tives of this review. There is currently no robust research evidence
to inform clinical decision-making regarding the prescription of
sleep positioning systems to reduce or prevent hip migration for
children with cerebral palsy.
The use of sleep positioning systems can be affected by many
different factors relating to (1) the equipment (availability, cost,
size, appearance, hygiene, temperature control, and transporta-
bility); (2) experience, skills, and training of therapists and car-
ers; (3) changing needs of the child; and (4) availability of alter-
native interventions (Polak 2007). Adverse effects appear under-
reported, perhaps because, in these instances, the equipment is
usually abandoned (Humphreys 2012; Pountney 2009); this key
outcome should be recorded and reported. Inability to adhere to
using sleep positioning systems is often assumed to be due to in-
sufficient skill or confidence on the part of carers, leading to a
focus on better training, but there are likely to be many other rea-
sons, including perceived discomfort and temperature regulation
(Innocente 2014). Both included and excluded studies reported
that children withdrew for reasons such as illness or a need for
other treatments. In some of the studies which did not recruit
existing users of sleep positioning systems, and were excluded for
methodological reasons, authors reported that some children also
withdrew, as their carers said the children could not sleep properly
when using their sleep positioning system.
The included studies recruited childrenwhowere established users
of sleep positioning systems and so provided no evidence as to the
principles used to identify appropriate children for sleep position-
ing systems, nor the reasoning for the type of sleep positioning sys-
tem used by the children. As these factors could have an influence
on the outcomes measured, it is important that this is explored
and documented in future research.
Despite the prescription of sleep positioning systems, there is little
evidence either regarding effectiveness or howbest to choose which
children are most likely to benefit. We also have no high quality
evidence to judge whether commercial sleep positioning systems
are more effective at reducing or preventing hip migration than
using cushions and pillows to aid positioning at night, which have
long been recommended by therapists (Bower 2008).
Quality of the evidence
The overall quality of evidence is very low. This review only found
two RCTs, including a total of 21 children, which examined the
effects of the intervention on two of the secondary objectives of
this review (pain and sleep patterns/quality). Both were judged
to have a high risk of bias and inadequate power related to small
samples and substantial individual variability in the outcomes as-
sessed. The restriction of the study sample to existing users of sleep
positioning systems limits the applicability of the evidence to the
general population of children with cerebral palsy. The applicabil-
ity of the data from the study conducted by Hill 2009 is reduced
further as this was carried out under laboratory conditions rather
than in the children’s homes.
Potential biases in the review process
Assessments for inclusion, risk of bias, and data extraction were
carried out independently by two review authors. Authors of the
included studies provided raw data and answered questions about
how the data had been analysed (on the basis of intention-to-
treat or not), which enabled more comprehensive appraisal of the
methods andfindings. Two authors (CM,GH) are part of a current
pilot RCT described in the Characteristics of ongoing studies and
one of these authors (GH) is also the author of an excluded study.
We avoided any potential conflict of interest by ensuring candidate
papers were not reviewed by the authors of these papers.
While the searches of the electronic databases were comprehensive,
a relatively high proportion of potential references - 15/37 (41%)
- were found through contact with manufacturers and authors
rather than through the electronic searches. Seven reports were not
published and three papers were published in journals not indexed
by the electronic databases, which highlights the importance of
using supplementary search methods. It is therefore possible that
other studies have been conducted but were not found, although it
is unlikely that they these would be large RCTs that would change
the conclusions of the review.
Agreements and disagreements with other
studies or reviews
In line with two other published reviews on sleep positioning sys-
tems for children with cerebral palsy (Bush 2013;Wynn 2009), we
concluded that there is limited evidence available of effectiveness
to prevent deformity. As Montero 2014 reported in their review
of studies looking at the technical devices used by children with
motor disabilities, the methodological quality of the available ev-
idence is low.
By highlighting the lack of well-designed RCTs, this review chal-
lenges an assumption reported in studies (Dawson 2013; Hill
2009), that sleep positioning systems are a proven, effective treat-
ment to reduce or prevent hip migration.
A consensus statement produced in 2006 proposed that a pro-
gramme of rigorous research to evaluate sleep positioning systems
was needed (Gericke 2006), but we found no evidence of studies
likely to provide definitive evidence.
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A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Recent guidance from the National Institute for Health and Care
Excellence (NICE) recommended that consideration be given to
using 24-hour postural management strategies to prevent or de-
lay the development of contractures or skeletal deformities (NICE
2012). However, this review provides no robust evidence of ef-
fectiveness or cost-effectiveness of commercial sleep positioning
systems to guide decision making for families and clinicians.
Sleep positioning systems are suggested to address a range of issues.
In the absence of research evidence, it is important that families
do not feel pressured to use or continue with sleep positioning
systems, especially if it disrupts their lives. Equally, it is important
to support families in persevering, if it is something they wish to
pursue.
As sleep positioning systems are expensive and frequently aban-
doned, occupational therapists and physiotherapists need further,
specific clinical guidance about how to assess whomight be appro-
priate and which system to recommend over another, if at all. As
the children typically prescribed sleep positioning systems (GM-
FCS Level IV or V) are often unable to express feelings of discom-
fort or pain (Gough 2009), careful consideration should be given
to how to assess the effects for individual children. Routine audit
of provision of sleep positioning systems may help identify which
children benefit from, and why children and families abandon us-
ing this equipment.
Implications for research
This review highlights the need for rigorously conducted RCTs to
assess the effectiveness and cost-effectiveness of sleep positioning
systems for children with cerebral palsy, and provide robust evi-
dence to inform clinical practice.
The conduct of such studies would be facilitated by the develop-
ment of an agreed set of appropriate and robust measures to assess
the outcomes, including potential adverse events, perceived to be
of importance to families and health professionals. The focus of
this review was the use of sleep positioning systems as a conser-
vative treatment to reduce or prevent hip migration. Whilst we
also considered other secondary outcomes, future research on sleep
positioning systems may broaden the scope to reduction or pre-
vention of other joint deformities (e.g. knee), loss of passive joint
range of motion and muscle contractures generally, comfort in ly-
ing, and/or risk of aspiration. Sleep positioning guidelines advise
caution for children with respiratory problems and those at risk of
aspiration (Polak 2009). Some children with cerebral palsy are at
increased risk of respiratory compromise/aspiration during sleep
(Fitzgerald 2009). One of the included studies - Hill 2009 - did
compare respiratory functioning in and out of sleep positioning
systems. While not identified as an outcome for this review, it is
important to consider the effects of sleep positioning systems on
respiratory function and the risk of aspiration. Outcomes pertain-
ing to hip migration, muscle shortening and deformity typically
occur over several years; hence there is a need for long-term follow-
up. Outcomes relating to pain, comfort, and sleep quality may be
more expedient and feasible to assess in trials over shorter time
periods.
The use of sleep positioning systems as part of 24-hour postu-
ral management can be considered a complex intervention (Craig
2008). Therefore, the therapeutic programme should be docu-
mented in detail in a manual, and fidelity to the prescribed in-
structions should also be assessed as adherence as part of any trial.
It will also be important for such studies to investigate any factors
that create difficulties or lead families to stop using the equip-
ment, such as when children sleep in different locations. The find-
ings and recommendations from theNIHR-funded pilot study (in
progress; UKCRN ID 10914) may provide further information
to inform the design of trials in this area.
Given the population for whom such interventions are most likely
to be recommended, it will be important to consider the potential
interaction with other forms of postural management equipment
(such as those designed to support the spine), as well as other
medical technologies (such as those for respiratory assistance while
sleeping), and coexisting conditions such as gastroesophageal re-
flux.
In the face of a lack of high quality evidence, it may be appropriate
to consider n-of-1 trials (single-subject clinical trials) to help in-
form decisions for individual children. Ameta-analysis of multiple
n-of-1 trials could then explore trends in the data, which might
identify the characteristics of children who respond, and any side
effects (Lillie 2011; Sedgwick 2014).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Hill 2009
Methods Within subject, cross-over study with randomised order of treatment using sealed en-
velopes. 2 nights attended polysomnography in paediatric research laboratory. Study ran
from January to April 2007
Participants Included
• 10 children: 5 boys; 5 girls
• Aged 5 to 16 years
• With cerebral palsy: GMFCS Level IV or V (8 spastic quadriplegic, 1 double
hemiplegic, and 1 hypertonia)
• Established sleep system users
Excluded
Children with poorly controlled/uncontrolled nocturnal seizures, unsettled domestic
situations, and extreme behavioural problems
Interventions • 1 night, children slept in their own sleep positioning system (9 x Symmetrisleep, 1
x Jenx Dreama), and 1 night, children slept in a bed with cot sides and no postural
support
• Each treatment was separated by at least 3 nights of sleep at home
Outcomes • Sleep quality: Onset latency; efficiency; % time in Stage 1, 2, 3, and 4 sleep; %
time in REM sleep; REM onset latency; total sleep time; number of REM cycles; and
total arousal index
• Respiratory function: SpO
minimum and mean; % time SpO
> 95%; Central Apnoea Index (CAI); Obstructive Apnoea Index (OAI); Hyopnea
Index (AHI); and Respiratory Arousal Index (RAI)
Polysomnographymeasured EEG (brain activity), EOG (eyemovements), EMG (muscle
tone), sleep stage, and detected arousals. Protech pressure transducer measured nasal
airflow. Piezo bands measured respiratory movements. Masimo technology took oxygen
measurements. Alice 5 (Respironics) software was used to integrate these physiological
signals. Time locked digital video was also taken and parents completed Paediatric Sleep
Questionnaire (PSQ) to look at snoring and daytime sleepiness scales
Notes Partly funded by manufacturer: Helping Hand Company (open grant with no require-
ment for approval of manuscript by company)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “randomisation to first night sleep-
ing condition”
Comment: Method of randomisation not
described
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Hill 2009 (Continued)
Allocation concealment (selection bias) Low risk Quote: “using a sealed envelope method”
Comment: Probably done
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not reported
Comment: Not possible to blind partici-
pants and personnel to the intervention;
potential risk of bias, particularly for sub-
jective outcomes
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not reported
Comment: Lack of blinding; potential risks
of bias, particularly subjective outcomes
collected by parent-report (PSQ). Lack of
blinding less likely to influence outcomes
measured by technology (e.g. polysomnog-
raphy/piezo bands). It may influence video
recording interpretation, but this outcome
not included in results
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Quote: “Subject 6 was excluded from
within subject analysis because of a pyrexial
illness on her second night”
Comment: Not enough information to
judge if missing outcome data were related
to true outcome
Selective reporting (reporting bias) High risk CANTAB tests in protocol were aban-
doned. 2 years from study completion to
publication
Other bias High risk Only 1 night in each condition. Did not
invite all eligible for the study (13/22). Re-
cruited existing users of sleep positioning
systems. Did not have number of children
required for intended statistical power
Underhill 2012
Methods Within subject, cross-over study with randomised order of treatment (method of ran-
domisation not described). 4 consecutive nights sleeping in/out of sleep positioning sys-
tem within their own home/residential care. Study ran from January 2009 to January
2011
Participants Included
• 11 children: 7 boys; 4 girls
• Age 5 to 15 years
• Types of cerebral palsy not stated. GMFCS Level III (n = 2), Level IV (n = 1), and
Level V (n = 8)
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Underhill 2012 (Continued)
• All children unable to walk independently and all normally use sleep positioning
systems for 6/7 nights at home/residential setting
Interventions • Children used their own sleep positioning system
◦ 5 x Symmetrisleep
◦ 5 x Chailey Lying Support
◦ 1 x Jenx Dreama
• Randomly allocated to sleep in their sleep positioning system (Monday to
Thursday) then an undefined wash-out period before conditions reversed
Outcomes • Sleep-wake patterns: Sleep onset latency; efficiency and actual sleep time measured
by Actigraph (Actiwatch type AW7) and averaged over 4 nights for each condition
• Pain: Parent reported through Paediatric Pain Profile (PPP) (20-item rating scale;
high score = severe pain)
• Parent carers also completed sleep diaries, Chailey Sleep Questionnaire, and brief
interviews at the end of each data collection period
Notes Funded by Nancie Finne Charitable Trust, which is now administered by the Chartered
Society of Physiotherapy (CSP) Charitable Trust
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “...were randomised to either sleep-
ing in their own sleep system or without
their sleep system first”
Comment: Method of randomisation not
described
Allocation concealment (selection bias) Unclear risk Not reported
Comment: Insufficient information topro-
vide judgement
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not reported
Comment: Not possible to blind partici-
pants and personnel to the intervention;
potential risk of bias, particularly subjective
outcomes
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not reported
Comment: Lack of blinding; potential risks
of bias, particularly subjective outcomes
collected by parent-report (PPP), but less
likely to influence outcomes collected by
Actigraph
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Underhill 2012 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Pain scores were not available for 1 child
(no reasons given). Sleep data not available
for 1 child as Actiwatch failed. 1 child slept
without sleep positioning system for only
2/4 nights but results included in analysis
without explanation as to how the datawere
averaged
Selective reporting (reporting bias) High risk Protocol reported measures such as mo-
tionless sleep and number of night awaken-
ings, which were not reported in published
paper. Findings were published a year after
study completion
Other bias High risk Recruited existing users of sleep position-
ing systems and did not have number
of children needed for intended statistical
power
AW: Actiwatch.
CANTAB: Cambridge Neuropsychological Testing Automated Battery.
GMFCS: Gross Motor Function Classification System.
EEG: electroencephalography.
EOG: electro-oculography.
EMG: electromyography.
REM: rapid eye movement.
SpO : peripheral capillary oxygen saturation.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Anon 2010 Product evaluation of 8 different sleep positioning systems
ASUNARO 2009 Case history of a 9-year-old. Outcome measures to improve symmetrical posture includes hip flexion
Dawson 2013 Within subject comparison study on ventilatory function. No randomisation. Existing users of sleep
positioning systems. 13/15 completed the trial. Age range 1 to 19 years
Goldsmith 2000 Descriptive study looking at sleep position, muscle tone, pain, and quality of sleep. New users of sleep
positioning systems. 28/42 still using sleep positioning systems after 1 year. Age range 9 months to
19 years
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(Continued)
Hankinson 2002 Pilot prospective cohort study looking at hip migration and sleep patterns. New users of sleep posi-
tioning systems. 7/14 completed the trial. Age range 4 to 14 years
Humphreys 2012 Descriptive study looking at quality of sleep, role of parents and therapists, and views of children. 7/
8 completed the trial. Age range 2 to 6 years
Innocente 2014 Postal survey of 16 users’ experiences of sleep positioning systems. Age range unclear
KAJITA 2010 Case history of a 6-year-old.Outcomemeasures were frequency of night awakenings and hip extension
and abduction measurements
May 2009 Survey of professionals using sleep positioning systems within residential homes
Mol 2012 Cross-sectional survey of 82 children. Both existing and new users of sleep positioning systems. Age
range 6 to 15 years
Polak 2007 Postal survey of 448 paediatric physiotherapists
Pountney 2002 Retrospective cohort study of 59 children looking at hip deformity, 24-hour posture management
systems not just sleep positioning systems. Age range 5 months to 18 years
Pountney 2009 Prospective cohort study looking at hip deformity, 24-hour posture management systems not just
sleep positioning systems. 39/52 children completed the trial. Age range 18 months to 5 years
Royden 2013 Retrospective cohort study looking at hip stability and quality of life. Only conference abstract
available
The Helping Hand Co 2002 Descriptive study looking at comfort, sleep patterns, and daytime activities. 4/9 completed the trial.
Age-range unclear but includes children under 5 years of age
Characteristics of ongoing studies [ordered by study ID]
UKCRN ID 10914
Trial name or title The effects of night positioning on sleep, postural deformity and pain in children and young people with
cerebral palsy - an exploratory study
Methods Feasibility randomised controlled trial (parallel groups design) across 4 regions of southernEngland. Allocation
by minimisation
Participants Included
Aim to recruit 50 children, aged 3 to 16 years with cerebral palsy (GMFCS Levels IV to V), who are not
walking independently and are not using sleep positioning systems
Excluded
Children with other conditions which may affect their musculoskeletal development or sleep quality
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UKCRN ID 10914 (Continued)
Interventions Intervention group
• Provided with one of three sleep positioning systems (Chailey, Dreama or Symmetrisleep)
• Carers trained in use of the system and ongoing support provided by local therapist
• Each child followed up at six months
Control group
• Usual care - child not using a commercial sleep positioning system
Outcomes • Development of musculoskeletal deformity (hip migration, spinal curvature, and lower limb range of
movement)
• Pain
• Sleep quality
Tools to be used: Chailey Sleep Questionnaire, Paediatric Pain Profile (PPP), Brief Pain Inventory (BPI), X-
rays
Starting date November 2011
Contact information Dr Donna Cowan (Chailey Heritage Clinical Services), donna.cowan@nhs.net
Notes Funded by National Institute Health Research for Patient Benefit Panel
GMFCS: Gross Motor Function Classification System.
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D A T A A N D A N A L Y S E S
This review has no analyses.
A D D I T I O N A L T A B L E S
Table 1. Summary and test statistics for variables of primary outcomes
Outcome Variable Defini-
tion
Study ID Num-
ber of par-
ticipants
Sleeping
in sleep
position-
ing system
Mean
(SD)
Sleep-
ing out of
sleep posi-
tioning
system
Mean
(SD)
Mean dif-
ference
(95% CI)
Paired t-test
t value P value
Sleep pat-
terns/sleep
quality
Sleep
latency
Time (in
min-
utes) to fall
asleep
Hill 2009 9* 69.1† (52.
6)
32.9 (26.
0)
36.2 (-
1.12 to 73.
45)
2.24 0.06
Hill 2009 8£ 64.1 (54.
0)
37.0 (24.
5)
27.1 (-
8.76 to 62.
89)
1.79 0.12
Underhill
2012
9 68.8 (49.
8)
80.1 (48.
1)
-11.3 (-30.
70 to 8.03)
-1.35 0.21
Sleep effi-
ciency
% of time
in bed ac-
tually
asleep
Hill 2009 9 80.7 (15.
4)
83.1 (12.
0)
-2.4 (-11.
77 to 7.04)
-0.58 0.58
Underhill
2012
10 76.2 (8.3) 73.8 (11.
1)
2.4 (-2.98
to 7.73)
1.00 0.34
Pain Pain Paediatric
Pain
Profile
(PPP) scale
(parent-
reported
scores)
Underhill
2012
10 11.3 (12.
1)
13.0 (14.
6)
-1.7 (-4.88
to 0.15)
-1.68 0.13
CI: Confidence intervals; ID: Identifier; SD: Standard Deviation
* Includes one participant who fell asleep before recording started (recorded as zero), as reported by Hill 2009.
£ Calculated without the participant who fell asleep before treatment (excluding zero score) to be comparable to Underhill 2012.
† Calculated from data supplied by author; reported as 65.9 in Hill 2009.
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Table 2. Summary statistics for other variables of sleep patterns/quality of sleep
Study Variable of sleep
quality
Number of par-
ticipants
Sleeping in
sleep position-
ing systems
Mean (SD)
Sleeping out of
sleep position-
ing system
Mean (SD)
Sleep-
ing in sleep po-
sitioning system
Median (IQR)
Sleeping out of
sleep position-
ing system
Median (IQR)
Underhill 2012 Total sleep time
(in minutes)¹
10 517.1 (54.4) 509.1 (72.5) 511.5 (52.5) 527.5 (117.5)
Hill 2009 Total sleep time
(in minutes)
9 349.9 (101.1) 427.7 (55.0) 412.5 (143.5)* 421.0 (89.0)*
Total sleep time
that was S1ˆ (%)
9 2.4 (2.2) 3.2 (2.4) 1.7 (1.1)* 3.6 (3.5)*
Total sleep time
that was S4ˆ (%)
9 33.3 (10.6) 29.0 (10.6) 29.2 (11.3) 28.0 (7.5)
Total sleep time
that was S3ˆ (%)
9 6.4 (1.7) 6.2 (2.4) 6.3 (2.2) 5.5 (3.8)
Total sleep time
that was S2ˆ (%)
9 46.4 (10.0) 50.5 (11.0) 48.7 (11.3) 49.7 (10.8)
REM onset la-
tency (in min-
utes)
9 159.0 (99.4) 204.3 (122.4) 190.0 (18.0) 187.0 (65.0)
Number of REM
cycles
9 3.3 (0.9) 2.9 (1.1) 4.0 (1.0)* 2.0 (2.0)
Total sleep time
that was REMˆ
(%)
9 11.5 (5.1) 11.0 (4.6) 10.7 (1.4) 11.1 (3.9)
Total arousal in-
dex
9 11.5 (6.5) 11.4 (5.0) 8.5 (6.0)* 10.8 (8.2)*
Central Apnoea
Index (CAI)
9 3.0 (8.0) 4.0 (9.9) 0.4 (0.4)* 0.6 (0.9)*
Respira-
tory Arousal In-
dex (RAI)
9 2.2 (3.7) 1.5 (2.5) 1.4 (1.9)* 0.6 (1.4)*
Apnoea
- Hypopnoea In-
dex (AHI)
9 1.9 (1.8) 0.9 (1.2) 2.6 (3.0) 0.4 (1.5)*
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Table 2. Summary statistics for other variables of sleep patterns/quality of sleep (Continued)
Ob-
structive Apnoea
Index (OAI)
9 0.5 (0.6) 0.4 (0.9) 0.3 (0.8)* 0.1 (0.3)*
% total sleep
time with SpO
> 95%
9 80.5 (29.0) 77.2 (28.1) 98.0 (19.9)* 87.8 (12.6)*
Average (mean)
SpO over total
time
9 95.7 (0.9) 96.2 (1.9) 95.0 (1.0)* 97.0 (2.0)*
Minimum SpO
(Nidus value)
9 92.7 (1.7) 90.6 (3.0) 92.0 (1.0)* 91.0 (3.0)*
IQR: Interquartile range; REM: Rapid eye movement; SD: Standard deviation; SpO : Peripheral capillary oxygen saturation
¹ Originally reported in hours and minutes, here given as minutes to be comparable.
ˆS1, S2, S3, S4 refer to the different stages of sleep; stages one to four.
All values in this table are calculated from data supplied by study authors. For results from Hill 2009, some discrepancies were found
between our calculations and the original publication. These are highlighted with an asterisk (*).
A P P E N D I C E S
Appendix 1. Electronic search strategies
Cochrane Library databases
Cochrane Central Register of Controlled Trials (CENTRAL)
Cochrane Database of Systematic Reviews (CDSR)
Database of Abstracts of Reviews of Effects (DARE)
Cochrane Methodology Register (CMR)
Health Technology Assessment (HTA) Database
NHS Economic Evaluation Database (EED)
#1 MeSH descriptor Cerebral Palsy explode all trees
#2 (cerebral NEXT palsy):ti,ab
#3 CP:ti,ab
#4 spastic*:ti,ab
#5 quadriplegi*:ti,ab
#6 tetrapleg*:ti,ab
#7 dipleg*:ti,ab
#8 MeSH descriptor Quadriplegia explode all trees
#9 (disab* NEAR/7 child*):ti,ab
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#10 (handicap* NEAR/3 child*):ti,ab
#11 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10)
#12 positioning:ti,ab
#13 (sleep* NEXT position*):ti,ab
#14 (sleep* NEXT system*):ti,ab
#15 (sleep NEXT management):ti,ab
#16 (sleep* NEXT support*):ti,ab
#17 (postural NEXT support*):ti,ab
#18 (postural NEXT position*):ti,ab
#19 (postural NEXT management):ti,ab
#20 (postural NEXT system*):ti,ab
#21 (night NEXT time NEXT support*):ti,ab
#22 (night NEXT time NEXT position*):ti,ab
#23 (lying NEXT support*):ti,ab
#24 (lying NEXT position*):ti,ab
#25 (supine NEXT position*):ti,ab
#26 chailey:ti,ab
#27 dreama:ti,ab
#28 sleepform:ti,ab
#29 moonlight:ti,ab
#30 symmetrisleep:ti,ab
#31 snoooo*:ti,ab
#32 “simple stuff works”:ti,ab
#33 (#12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26
OR #27 OR #28 OR #29 OR #30 OR #32)
#34 (#11 AND #33)
Ovid MEDLINE
1 Cerebral Palsy/
2 cerebral palsy.ti,ab.
3 CP.ti,ab.
4 spastic*.ti,ab.
5 quadriplegi*.ti,ab.
6 Quadriplegia/
7 tetraplegi*.ti,ab.
8 diplegi*.ti,ab.
9 disabled children/
10 (disab* adj7 child*).ti,ab.
11 (handicap* adj3 child*).ti,ab.
12 or/1-11
13 positioning.ti,ab.
14 sleep* position*.ti,ab.
15 sleep system*.ti,ab.
16 sleep management.ti,ab.
17 sleep* support*.ti,ab.
18 postural support*.ti,ab.
19 postural position*.ti,ab.
20 postural management.ti,ab.
21 postural system*.ti,ab.
22 night time support*.ti,ab.
23 night time position*.ti,ab.
24 lying support*.ti,ab.
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25 lying position*.ti,ab.
26 supine position*.ti,ab.
27 chailey.ti,ab.
28 dreama.ti,ab.
29 sleepform.ti,ab.
30 moonlight.ti,ab.
31 moonlite.ti,ab.
32 symmetrisleep.ti,ab.
33 snoooo*.ti,ab.
34 simple stuff works.ti,ab.
35 or/13-34
36 12 and 35
Ovid EMBASE
1 Cerebral Palsy/
2 cerebral palsy.ti,ab.
3 CP.ti,ab.
4 spastic*.ti,ab.
5 quadriplegi*.ti,ab.
6 Quadriplegia/
7 tetraplegi*.ti,ab.
8 diplegi*.ti,ab.
9 disabled children/
10 (disab* adj7 child*).ti,ab.
11 (handicap* adj3 child*).ti,ab.
12 or/1-11
13 positioning.ti,ab.
14 sleep* position*.ti,ab.
15 sleep system*.ti,ab.
16 sleep management.ti,ab.
17 sleep* support*.ti,ab.
18 postural support*.ti,ab.
19 postural position*.ti,ab.
20 postural management.ti,ab.
21 postural system*.ti,ab.
22 night time support*.ti,ab.
23 night time position*.ti,ab.
24 lying support*.ti,ab.
25 lying position*.ti,ab.
26 supine position*.ti,ab.
27 chailey.ti,ab.
28 dreama.ti,ab.
29 sleepform.ti,ab.
30 moonlight.ti,ab.
31 moonlite.ti,ab.
32 symmetrisleep.ti,ab.
33 snoooo*.ti,ab.
34 simple stuff works.ti,ab.
35 or/13-34
36 12 and 35
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Cumulative Index to Nursing and Allied Health Literature (CINAHL) (EBSCOhost)
S32 (S10 or S11 or S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20 or S21 or S22 or S23 or S24 or S25 or S26 or S27
or S28 or S29 or S30) AND (S9 and S31)
S31 S10 or S11 or S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20 or S21 or S22 or S23 or S24 or S25 or S26 or S27
or S28 or S29 or S30
S30 TI “simple stuff works” OR AB “simple stuff works”
S29 TI snoooo* OR AB snoooo*
S28 TI symmetrisleep OR AB symmetrisleep
S27 TI moonlight OR AB moonlight OR TI moonlite OR AB moonlite
S26 TI sleepform OR AB sleepform
S25 TI dreama OR AB dreama
S24 TI chailey OR AB chailey
S23 TI “supine position*” OR AB “supine position*”
S22 TI “lying position*” OR AB “lying position*”
S21 TI “lying support*” OR AB “lying support*”
S20 TI “night time position*” OR AB “night time position*”
S19 TI “night time support*” OR AB “night time support*”
S18 TI “postural system*” OR AB “postural system*”
S17 TI “postural management” OR AB “postural management”
S16 TI “postural position*” OR AB “postural position*”
S15 TI “postural support*” OR AB “postural support*”
S14 TI “sleep support*” OR AB “sleep support*”
S13 TI “sleep management” OR AB “sleep management”
S12 TI “sleep system*” OR AB “sleep system*”
S11 TI “sleep position*” OR AB “sleep position*”
S10 TI Positioning OR AB Positioning
S9 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8
S8 TI handicap* N7 child* OR AB handicap* N7 child*
S7 TI disab* N7 child* OR AB disab* N7 child*
S6 TI dipleg* OR AB dipleg*
S5 TI tetraplegi* OR AB tetraplegi*
S4 TI quadriplegi* OR AB quadripleg*
S3 TI spastic* OR AB spastic*
S2 TI CP OR AB CP
S1 TI “cerebral palsy” OR AB “cerebral palsy”
British Nursing Index (ProQuest)
S33 S9 and S32
S32 TI,AB(positioning) ORTI,AB(“sleep position*”) OR TI,AB(“sleep system*”) ORTI,AB(“sleep management*”) ORTI,AB(“sleep
management”) OR TI,AB(“sleep* support*”) OR TI,AB(“postural support*”) OR TI,AB(“postural position*”) OR TI,AB(“postural
management”) OR TI,AB(“postural system*”) OR TI,AB(“night time support”) OR TI,AB(“night time position*”) OR TI,AB(“lying
support*”) ORTI,AB(“lying position*”) ORTI,AB(“supine position*”) ORTI,AB(chailey) ORTI,AB(dreama) ORTI,AB(sleepform)
OR TI,AB(moonlight) OR TI,AB(symmetrisleep) OR TI,AB(snoooo*) OR TI,AB(“simple stuff works”)
S31 TI,AB(“simple stuff works”)
S30 TI,AB(snoooo*)
S29 TI,AB(symmetrisleep)
S28 TI,AB(moonlight)
S27 TI,AB(sleepform)
S26 TI,AB(drama)
S25 TI,AB(chailey)
S24 TI,AB(“supine position*”)
S23 TI,AB(“lying position*”)
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S22 TI,AB(“lying support*”)
S21 TI,AB(“night time position*”)
S20 TI,AB(“night time support”)
S19 TI,AB(“postural system*”)
S18 TI,AB(“postural management”)
S17 TI,AB(“postural position*”)
S16 TI,AB(“postural support*”)
S15 TI,AB(“sleep* support*”)
S14 TI,AB(“sleep management”)
S13 TI,AB(“sleep management*”)
S12 TI,AB(“sleep system*”)
S11 TI,AB(“sleep position*”)
S10 TI,AB(positioning)
S9 TI,AB(“cerebral palsy”) OR TI,AB(CP) OR TI,AB(spastic*) OR TI,AB(quadriplegi*) OR TI,AB(tetraplegi*) OR TI,AB(diplegi*)
OR TI,AB(disabled NEAR/7 child*) OR TI,AB(handicap* NEAR/3 child*)
S8 TI,AB(handicap* NEAR/3 child*)
S7 TI,AB(disabled NEAR/7 child*)
S6 TI,AB(diplegi*)
S5 TI,AB(tetraplegi*)
S4 TI,AB(quadriplegi*)
S3 TI,AB(spastic*)
S2 TI,AB(CP)
S1 TI,AB(“cerebral palsy”)
Health Management Information System (Ovid)
1 Cerebral Palsy/
2 cerebral palsy.ti,ab.
3 CP.ti,ab.
4 spastic*.ti,ab.
5 quadriplegi*.ti,ab.
6 Quadriplegia/
7 tetraplegi*.ti,ab.
8 diplegi*.ti,ab.
9 disabled children/
10 (disab* adj7 child*).ti,ab.
11 (handicap* adj3 child*).ti,ab.
12 or/1-11
13 positioning.ti,ab.
14 sleep* position*.ti,ab.
15 sleep system*.ti,ab.
16 sleep management.ti,ab.
17 sleep* support*.ti,ab.
18 postural support*.ti,ab.
19 postural position*.ti,ab.
20 postural management.ti,ab.
21 postural system*.ti,ab.
22 night time support*.ti,ab.
23 night time position*.ti,ab.
24 lying support*.ti,ab.
25 lying position*.ti,ab.
26 supine position*.ti,ab.
27 chailey.ti,ab.
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28 dreama.ti,ab.
29 sleepform.ti,ab.
30 moonlight.ti,ab.
31 moonlite.ti,ab.
32 symmetrisleep.ti,ab.
33 snoooo*.ti,ab.
34 simple stuff works.ti,ab.
35 or/13-34
36 12 and 35
Conference Proceedings Citation Index - Science; and Conference Proceedings Citation Index - Social
Sciences and Humanities (Web of Science)
# 32 #31 AND #9
# 31 #30 OR #29 OR #28 OR #27 OR #26 OR #25 OR #24 OR #23 OR #22 OR #21 OR #20 OR #19 OR #18 OR #17 OR #16
OR #15 OR #14 OR #13 OR #12 OR #11 OR #10
# 30 TS=(“simple stuff works”)
# 29 TS=(snoooo*)
# 28 TS=(symmetrisleep)
# 27 TS=(moonlight or moonlite)
# 26 TS=(sleepform)
# 25 TS=(dreama)
# 24 TS=(chailey)
# 23 TS=(“supine position*”)
# 22 TS=(“lying position*”)
# 21 TS=(“lying support*”)
# 20 TS=(“night time position*”)
# 19 TS=(“night time support*”)
# 18 TS=(“postural system*”)
# 17 TS=(“postural management”)
# 16 TS=(“postural position”)
# 15 TS=(“postural support”)
# 14 TS=(“sleep* support”)
# 13 TS=(“sleep* management”)
# 12 TS=(“sleep* system*”)
# 11 TS=(“sleep* position*”)
# 10 TS=(positioning)
# 9 #8 OR #7 OR #6 OR #5 OR #4 OR #3 OR #2 OR #1
# 8 TS=(handicap* Near/3 child*)
# 7 TS=(disabled Near/7 child*)
# 6 TS=(“disabled children”)
# 5 TS=((quadriplegi* or tetraplegi* or diplegi*))
# 4 TS=(spastic*)
# 3 TS=(CP.ti,ab)
# 2 TS=(cerebral palsy)
# 1 TS=(cerebral palsy)
PEDro (Physiotherapy Evidence Database)
Cerebral palsy AND sleep*
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OTSeeker (Occupational Therapy Systematic Evaluation of Evidence)
Cerebral palsy AND sleep*
Clinical trials
clinicaltrials.gov
Cerebral palsy AND sleep
World Health Organisation (WHO) International Clinical Trials Registry Platform (ICTRP)
who.int/ictrp/en
Cerebral palsy AND sleep
WorldCat
kw:cerebral palsy kw:sleep
Appendix 2. Additional methods table
Measures of treatment effect Where continuous data are presented butmeasured indifferentways across
studies (e.g. physical functioning scores), we plan to calculate standardised
mean differences (SMD) with 95% confidence intervals (CIs). We plan
to use the same techniques where outcomes are ordinal. We plan to use
the relative risk (RR) with 95% CIs as the measures of effect for each
dichotomous outcome. If there is only one study for a particular outcome,
or if the outcome is measured in the same way across studies, we plan to
use the mean difference (MD) with 95% confidence intervals
Unit of analysis issues We anticipate that future studies could use a cross-over design. If so,
we will attempt to obtain standard errors based on paired data. If this
information is not provided we will attempt to infer it (see ’Dealing with
missing data’ section). If we cannot obtain data for a paired analysis, we
will treat the cross-over trial as a parallel group trial with information from
the first period only
Dealing with missing data We will approach the authors directly for information:
• where outcomes of interest may have been measured but were not
reported; and
• where study-level characteristics are needed to investigate
heterogeneity but were not reported.
If it is not possible to obtain the data from the original investigators, we
will analyse the available data separately, and explore the potential impact
of missing data on the findings of the review in the ’Discussion’ section.
We will collect the proportions of participants for whom no outcome data
are obtained and report this in the ’Risk of bias’ assessment
If cross-over designs are reported in studies without information on the
standard error of within-individual differences, we will attempt to obtain
it using one of the following (in priority order):
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(Continued)
• infer from other statistical information provided (e.g. t-statistic
from a paired test);
• individual participant data from the original investigators; or
• by imputation using correlations obtained from other studies
(Elbourne 2002; Higgins 2011b).
Assessment of heterogeneity Where there are sufficient data, we will calculate a summary statistic for
each outcome using both fixed-effect and random-effects models. We will
combine outcomes only if it is sensible to do so, and we will interpret
results cautiously. We will consider methodological heterogeneity (differ-
ences in study design) and clinical heterogeneity (differences in partici-
pants, interventions or outcome measures). We will assess heterogeneity
by examining the scatter in the data points and the overlap of the confi-
dence intervals, as well as by performing Chi². Any result with a P value
greater than 0.05 will be considered to be heterogeneous. We will cau-
tiously explore reasons for heterogeneity and, data permitting, assess it
further with subgroup analysis or meta-regression
Assessment of reporting bias Publication and other reporting bias
We will examine included studies to check for duplication of results (i.e.
whether the same data have been analysed and presented more than once)
. In these cases, we will contact the authors and request further details
and individual participant data. If sufficient data are available, we will
produce a funnel plot from the outcome data and and explore the reasons
for asymmetry such as poor methodological quality or heterogeneity
Subgroup analysis and investigation of heterogeneity If sufficient trials are available in the future, and statistical heterogeneity
is evident, we will examine the following subgroups to explore clinical
heterogeneity:
• types of cerebral palsy (e.g. spastic, ataxic, dyskinetic/athetoid);
• severity of cerebral palsy (as classified by the Gross Motor Function
Classification System (GMFCS));
• age (e.g. < five years (pre-school), 5 to 12 years (pre-adolescent), 12
to 18 years (adolescent));
• variations in frequency, intensity and duration of the intervention;
and
• methodological quality.
Sensitivity analysis If sufficient trials are available in the future, we will conduct sensitivity
analyses by repeating the analysis with the following exclusions:
• trials which do not clearly state allocation concealment, or where
allocation concealment is inadequate;
• trials which do not clearly state blinding of outcome assessors, or
where blinding of outcome assessors is inadequate;
• trials where the definition of the comparison intervention is not
clear; and
• trials in which there are clinically significant differences in baseline
characteristics.
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H I S T O R Y
Protocol first published: Issue 7, 2011
Review first published: Issue 11, 2015
Date Event Description
13 May 2014 Amended Search strategy updated
C O N T R I B U T I O N S O F A U T H O R S
Sharon F Blake co-ordinated the review, undertook searches, screened search results, organised retrieval of papers, wrote to authors and
manufacturers, screened and appraised papers, extracted data, entered data into RevMan software, and wrote the first draft.
Stuart Logan conceptualised the review, provided clinical and policy perspective, and contributed to writing of the review.
Ginny Humphreys conceptualised and designed the review, provided clinical perspective, and edited the draft.
Justin Matthews analysed the data and contributed to writing of the review.
Morwenna Rogers designed the search strategy, undertook searches, organised retrieval of papers, screened search results, extracted data,
and edited the draft.
Joanna Thompson-Coon provided methodological perspective, resolved disagreements during screening, and contributed to writing
of the review.
Katrina Wyatt conceptualised, designed, and contributed to writing of the review.
Christopher Morris designed and managed the methodology and conduct of the review, screened search results, screened and appraised
papers, extracted data, and contributed to writing of the review.
D E C L A R A T I O N S O F I N T E R E S T
This review benefited from support from National Institute for Health Research (NIHR) Collaboration for Leadership in Applied
Health Research and Care of the SouthWest Peninsula (PenCLAHRC) and the charity Cerebra. They had no influence on the conduct
or reporting of the work. The views and opinions expressed in this paper are those of the authors and not necessarily those of the NHS,
the NIHR, the Department of Health, or Cerebra.
Stuart Logan, Ginny Humphreys, Morwenna Rogers, Joanna Thompson-Coon, Katrina Wyatt and Christopher Morris are or have
been chief or co-investigators on NIHR grants and/or grants from other funding agencies unrelated to this review, unless otherwise
declared.
Sharon F Blake- none known.
Stuart Logan - none known.
Ginny Humphreys is the author of an excluded study Humphreys 2012. She has not been involved in the assessment of eligibility,
risk of bias, and data extraction for this review. Ginny Humphreys and Christopher Morris are co-investigators for a pilot randomised
controlled trial (RCT) evaluating sleep positioning systems for the same population UKCRN ID 10914 which is an ongoing study.
Two independent authors, Sharon Blake and Morwenna Rogers, assessed the eligibility of this study and found that it would meet the
criteria for inclusion. No data were available at the time of writing. When data become available, the author team will ensure that the
’Risk of bias’ assessment and data extraction will be carried out by independent authors who have not been involved in this study.
Justin Matthews - none known.
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Morwenna Rogers - none known.
Joanna Thompson-Coon - none known.
Katrina Wyatt - none known.
Christopher Morris declares that none of his declared potential conflicts of interest have knowingly biased the work he has done on
this Cochrane review.
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West
Peninsula at the Royal Devon and Exeter NHS Foundation Trust (PenCLAHRC), UK.
Staff time and other resources for the review.
The views expressed are those of the authors and not necessarily those of the NIHR, National Health Service, or the Department of
Health.
• Cerebra, UK.
Staff time and other resources for the review.
The views expressed are those of the authors and not necessarily those of Cerebra.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We updated our search strategy in 2014 to include different spellings of moonlite/moonlight and to include databases recommended
by the Cochrane Review Group (trial registers, Conference Proceedings Citation Index and WorldCat Dissertations).
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